Short Report

You have full text access to this OnlineOpen article

Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers

  1. Susan Neuhausen1,
  2. Alison Dunning2,
  3. Linda Steele1,
  4. Kazuko Yakumo4,
  5. Michael Hoffman4,
  6. Csilla Szabo5,
  7. Louise Tee2,
  8. Caroline Baines2,
  9. Paul Pharoah2,
  10. David Goldgar5,†,*,
  11. Doug Easton3

Article first published online: 21 OCT 2003

DOI: 10.1002/ijc.11385

Issue

International Journal of Cancer

International Journal of Cancer

Volume 108, Issue 3, pages 477–478, 20 January 2004

Additional Information

How to Cite

Neuhausen, S., Dunning, A., Steele, L., Yakumo, K., Hoffman, M., Szabo, C., Tee, L., Baines, C., Pharoah, P., Goldgar, D. and Easton, D. (2004), Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers. Int. J. Cancer, 108: 477–478. doi: 10.1002/ijc.11385

Author Information

  1. 1

    Division of Epidemiology, Department of Medicine, University of California, Irvine, CA, USA

  2. 2

    Human Cancer Genetics Research Group, Strangeways Research Laboratories, Cambridge, United Kingdom

  3. 3

    Cancer Research U.K. Genetic Epidemiology Unit, Strangeways Research Laboratories, Cambridge, United Kingdom

  4. 4

    Department of Family and Preventive Medicine, University of Utah, Salt Lake City, UT, USA

  5. 5

    International Agency for Research on Cancer, Lyon, France

  1. †

    Fax: +33-4-72-73-83-42

*International Agency for Research on Cancer, 150 Cours Albert Thomas, 69008 Lyon France

Publication History

  1. Issue published online: 21 NOV 2003
  2. Article first published online: 21 OCT 2003
  3. Manuscript Accepted: 6 MAY 2003
  4. Manuscript Revised: 2 MAY 2003
  5. Manuscript Received: 5 DEC 2002

Funded by

  • Cancer Research U.K.
  • NCI. Grant Number: NIH CA74415
  • American Cancer Society. Grant Number: RPG-99-181-01CCE
  • Kirby Foundation
  • Utah Cancer Registry. Grant Number: NO1-CN-6700
  • Utah State Department of Health
  • SwissBridge Foundation

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (44K)

REFERENCES

  • 1
    ParkinDM, WhelanSL, FerlayJ, RaymondL, YoungJ, eds. Cancer incidence in five continents. Vol. VII, IARC Sci Publ Vol. 143, Lyon: International Agency for Research on Cancer, 1997.
  • 2
    Anderson DE, Badzioch MD. Breast cancer risks in relatives of male breast cancer patients. J Natl Cancer Inst 1992; 84: 1114–17.
  • 3
    Rosenblatt KA, Thomas DB, McTiernan A, Austin MA, Stalsberg H, Stemhagen A, Thompson WD, Curnen MG, Satariano W, Austin DF, et al. Breast cancer in men: aspects of familial aggregation. J Natl Cancer Inst 1991; 83: 849–54.
  • 4
    Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families: The Breast Cancer Linkage Consortium. Am J Hum Genet 1998; 62: 676–89.
  • 5
    Basham VM, Lipscombe JM, Ward J, Gayther SA, Ponder BAJ, Easton D, Pharoah P. BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res 2002, 4: R2.
  • 6
    Struewing JP, Coriaty ZM, Ron E, Livoff A, Konichezky M, Cohen P, Resnick MB, Lifzchiz-Mercerl B, Lew S, Iscovich J. Founder BRCA1/2 mutations among male patients with breast cancer in Israel. Am J Hum Genet 1999; 65: 1800–2.
  • 7
    Mavraki E, Gray IC, Bishop DT, Spurr NK. Germline BRCA2 mutations in men with breast cancer. Br J Cancer 1997; 76: 1428–31.
  • 8
    Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, Ponder BA, Anton-Culver H. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 1997; 60: 313–9.
  • 9
    CHEK2 Breast Cancer Consortum. Low penetrance susceptibility of breast cancer due to CHEK2*1100delC in non-carriers of BRCA1 or BRCA2 mutations. Nature Genet 2002; 31: 55–59.
  • 10
    Vahteristo P, Bartkova J, Eerola H, Syrjakoski K, Ojala S, Kilpivaara O, Tamminen A, Kononen J, Aittomaki K, Heikkila P, Holli K, Blomqvist C, et al. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 2002; 71: 432–8.
  • 11
    Lee JS, Collins KM, Brown AL, Lee CH, Chung JH. hCds-1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 2000; 404: 201–204
  • 12
    Lee SB, Kim SH, Bell DW, Wahrer DC, Schiripo TA, Jorczak MM, Sgroi DC, Garber JE, Li FP, Nichols KE, Varley JM, Godwin AK, Shannon KM, et al. Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni syndrome. Cancer Res 2001; 61: 8062–7.
View Full Article (HTML) Get PDF (44K)